Prevention of migraine in women throughout the life span.
Migraine is a common disorder in women. The 1-year prevalence of migraine is 18% in women compared with 6% in men. Migraine most commonly occurs during the reproductive years, affecting 27% of women 30 to 49 years of age. The predominance of this disorder and its social, functional, and economic consequences make migraine an important issue in women's health. The hormonal milieu has a substantial effect on migraine in women. An understanding of these hormonal influences in the various stages of life in females is essential to the management and prevention of migraines. This article reviews migraine prevention strategies with an emphasis on specific therapies for each stage of a woman's life.
Tozer
Beverly S
BS
Division of Women's Health Internal Medicine, Mayo Clinic College of Medicine, 13400 E Shea Blvd, Scottsdale, AZ 85259, USA.
Boatwright
Elizabeth A
EA
David
Paru S
PS
Verma
Deepa P
DP
Blair
Janis E
JE
Mayer
Anita P
AP
Files
Julia A
JA
D018450:Disease Progression; D005260:Female; D006801:Humans; D008881:Migraine Disorders / Q000453:epidemiology / Q000517:prevention & control*; D015995:Prevalence; D014481:United States / Q000453:epidemiology; D016387:Women's Health